Pacer Advisors
BCRX icon

Pacer Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Pacer Advisors’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9M Buy
+1,563,040
New +$12.1M 0.04% 368
2024
Q3 		– Sell
-2,649
Closed -$16.4K – 2578
2024
Q2 		$16.4K Sell
2,649
-4,657
-64% -$25.7K ﹤0.01% 3465
2024
Q1 		$37.1K Buy
+7,306
New +$41.1K ﹤0.01% 3291
2021
Q2 		– Sell
-6,177
Closed -$63K – 1424
2021
Q1 		$63K Sell
6,177
-9,768
-61% -$101K ﹤0.01% 1408
2020
Q4 		$119K Sell
15,945
-8,558
-35% -$44.1K ﹤0.01% 1336
2020
Q3 		$84K Buy
+24,503
New +$105K ﹤0.01% 1274
2018
Q4 		– Sell
-7,158
Closed -$55K – 581
2018
Q3 		$55K Buy
+7,158
New +$48.1K ﹤0.01% 1139
2018
Q1 		– Sell
-2,100
Closed -$10K – 1045
2017
Q4 		$10K Buy
+2,100
New +$10.2K ﹤0.01% 1142

Other funds holding BCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return